U.K. aims for growth capital influx by taking leash off pension funds 

The U.K. government’s move to allow pensions to allocate more capital to unlisted equities could be a watershed moment for greatly improving access to capital for the U.K.’s life sciences sector. But investors want to see it done in a diversified, measured way to maximize its chances of helping grow the sector.

Life sciences leaders have been calling for years to facilitate pension fund investments into the U.K.’s growth industries, including biopharma. The U.K. agreement is the first step in the process...